Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-08-02
2005-08-02
Housel, James (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C424S141100, C424S147100, C424S149100, C435S005000, C435S007100, C435S069100
Reexamination Certificate
active
06924362
ABSTRACT:
The present invention describes the identification and characterization of five human HC E1-specific monoclonal antibodies isolated from a phage display library and their use in the diagnosis, treatment, and prevention of HCV in mammals, preferably humans.
REFERENCES:
patent: 5308750 (1994-05-01), Mehta et al.
patent: 6521403 (2003-02-01), Maertens et al.
patent: 6538114 (2003-03-01), Persson et al.
patent: 6692908 (2004-02-01), Foung et al.
patent: WO 97/40176 (1997-10-01), None
patent: WO 98/16647 (1998-04-01), None
Allander T. et al. 2000 Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81.J Gen Virol.81(Pt10):2451-2459.
Burioni R. et al. 1998 Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments.Hepatology28(3):810-814.
Chan SW. et al. 1996 Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library.J Gen Virol.77(Pt10):2531-2539.
Farci P. et al. 1994 Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.PNAS USA91(16):7792-7796.
Farci P. et al. 1996 Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.PNAS USA93(26):15394-15399.
Hadlock KG. et al. 2000 Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.J Virol.74(22):10407-10416.
Plaisant P. et al. 1997 Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors.Res Virol.148(2):165-169.
Shimizu YK. et al. 1996 A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.Virology.223(2):409-412.
Zhai W. et al. 1999 Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.J Viral Hepat.6(2):115-24.
Alter Harvey J.
Emerson Suzanne U.
Purcell Robert H.
Schofield Darren
Housel James
Knobbe Martens Olson & Bear LLP
McGaw Michael M.
The United States of America as represented by the Department of
LandOfFree
Monoclonal antibodies specific for the E2 glycoprotein of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies specific for the E2 glycoprotein of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies specific for the E2 glycoprotein of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3493628